Eli Lilly and Company (LLY)
Eli Lilly and Company Beneish M-Score: -2.821
View LLY Beneish M-Score with YCharts Pro.
Access these YCharts Pro features:
Export any data you want
Save any chart as an image
Utilize advanced screener power
View 30 years of financial history
over 90 advanced calculations
Enjoy an advertising free experience
LLY Beneish M-Score Rankings
| Overall | 66th percentile | 1271 of 3770 |
| Sector | 76th percentile | 82 of 342 in Healthcare |
| Industry | 94th percentile | 1 of 17 in Drug Manufacturers - Major |
LLY Beneish M-Score Range, Past 5 Years
| Minimum | -4.248 | Dec 2008 |
| Maximum | -2.329 | Dec 2009 |
| Average | -2.890 |
About Beneish M Score
The Beneish M Score helps to uncover companies who are likely to be manipulating their reported earnings. Companies with a higher score are more likely to be manipulators. This is a probabilistic model, so it will not detect manipulators with 100% accuracy.
The best cut-off point depends on the costs mistakenly classifying in one of two ways:
1) Classifying firm that is manipulating earnings as a non-manipulator (Type I error), and
2) Classifying a firm as a manipulator when it actually was not manipulating (Type II Error).
Here are optimal cut-offs according to Beneish, presented as the score followed by the cost of Type I error relative to cost of Type II error):
M Score HTML Table:
| Score | Relative Error Costs (Type I:Type II) |
|---|---|
| M Score > -1.49 | (10:1) | M Score > -1.78 | (20:1) | M Score > -1.89 | (40+:1) |
Beneish excluded financial institutions from his sample when calculating the M-Score, so extreme care should be taken when looking at M-Scores of financial firms - their business models are different from the manufacturing and other service firms that Beneish used in his study.
If you want more details, here is the original Beneish M Score Paper, or you can learn about our calculation by clicking "Learn More" below.
Learn More
You may also be interested in these LLY related companies
LLY News
Boehringer Ingelheim, Lilly (LLY) Say Linagliptin Showed Significant Improvement in HbA1c in Phase 3
May 24, 9:02AM Street Insider
May 24, 9:02AM Street Insider
Pharma has been a place to hide in pullback, but there are many fewer names that look healthy. $PFE still holding, $LLY looks ready to drop
about 11 days ago by harmongreg
about 11 days ago by harmongreg
$PFE $LLY $GSK So this is the condition some drug commercials warned us about! And we thought they were kidding. http://stks.co/3q2n
about 15 days ago by laughing_stock
about 15 days ago by laughing_stock
The Drama Continues At $AMLN: Takeover Still Likely. $BMY $LLY $SNY http://stks.co/3prL
about 15 days ago by abubnic
about 15 days ago by abubnic
Lilly Oncology to Highlight Final Results for Phase III Study in Most Common Form of Lung Cancer
May 14, 9:00AM PR Newswire
May 14, 9:00AM PR Newswire
Ex-Dividend Stocks: DuPont, AK Steel http://stks.co/3lBo My story via @TheStreet $DD $AKS $LLY $BTU $EXC $HLF #ExDividend #Dividend
about 20 days ago by azendrian
about 20 days ago by azendrian
$LLY MACDBullish Trend Chart pat UpTrend RSI Bullish Up/Down vol pat under Accum 50/200d MA Bullish Support 39.47 above Resis 40.12 Bullis
about 24 days ago by MACDaddy
about 24 days ago by MACDaddy
Stock Trading Ideas for the Week of 5/7/12 http://stks.co/3gjx via @alphatrends $LLY $ARBA $MM
about 24 days ago by StockTwits
about 24 days ago by StockTwits
FDA Approves Amyvid for Alzheimer’s Diagnosis. $LLY http://stks.co/3ZNn
about 31 days ago by abubnic
about 31 days ago by abubnic
News related to $LLY, currently +0.3% since open: 'ImmunoGen fiscal 3Q loss widens as expenses rise' http://stks.co/3YQK
about 33 days ago by TradeBot
about 33 days ago by TradeBot
$LLY another strong healthcare name trying to breakout. Low volatility also vs SPX. $XLV http://stks.co/3Xg3
about 34 days ago by tradewithpete
about 34 days ago by tradewithpete
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| LLY | 41.00 | -0.30 | -0.73% | 47.92B |
| LLTC | 29.09 | -0.33 | -1.12% | 6.737B |
| LLNW | 2.74 | -0.03 | -1.08% | 288.69M |
| LLL | 67.63 | -0.27 | -0.40% | 6.715B |
| LLEN | 1.59 | -0.10 | -5.92% | 55.60M |
| LL | 29.40 | -0.58 | -1.93% | 840.04M |
| LKQX | 36.28 | +0.75 | +2.11% | 5.345B |
| KERX | 1.65 | -0.05 | -2.94% | 120.73M |
| KEQU | 8.25 | -0.02 | -0.24% | 21.28M |
| KEP | 9.40 | -0.12 | -1.26% | 12.22B |